| abstract |
The present invention relates to the use of eucalyptus extracts in the manufacture of pharmaceuticals or food supplements for use in the treatment and / or prevention of diseases or pathologies caused by abnormal reuptake of neurotransmitters. One or more compounds of formula (I) wherein R1 together with the carbon to which it is attached form a C═CH 2 substituent, a formula (II) substituent, and R 2 is an isobutyl, α-isobutyl or β-isobutyl substituent Or it relates to a strengthened eucalyptus extract, characterized in that it contains diastereomers thereof and a method for producing the same. |